Gilead Sciences Switzerland Sàrl - Harvoni, Filmtabletten | | 65331 | | 01 | | Harvoni | | Filmtabletten | | J05AP51 | | Sofosbuvir and Ledipasvir | | 16.12.2014 | | |
| Composition | sofosbuvirum 400 mg, ledipasvirum 90 mg, copovidonum, lactosum monohydricum 165 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 4.752 mg, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 110 0.3 mg, pro compresso obducto. | Packungsbestandteile | | Coated tablets | | | Active Agent | Dose |
---|
Ledipasvirum | 90 mg | Sofosbuvirum | 400 mg |
| BAG: Active Agent | Dose |
---|
Ledipasvirum | 90 mg | Sofosbuvirum | 400 mg |
| | Inactive agents | Dose | additional_information |
---|
Carmellosum Natricum Conexum | | | Cellulosum Microcristallinum | | | Copovidonum | | | E 110 | 0.3 mg | color. | E 171 | | color. | Lactose Monohydrate | 165 mg | | Macrogol | 3350 | | Magnesii Stearas | | | Poly(Alcohol Vinylicus) | | Überzug | Pro Compresso Obducto | | | Silica Colloidalis Anhydrica | | | Talcum | | |
| |
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
---|
No entries have been found. |
|
|